Apex Biotechnology Corp
TWSE:1733
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
Apex Biotechnology Corp
TWSE:1733
|
TW |
|
Pensana PLC
LSE:PRE
|
UK |
|
IDFC Ltd
NSE:IDFC
|
IN |
|
R
|
Royal Bafokeng Platinum Ltd
JSE:RBP
|
ZA |
|
Elis SA
PAR:ELIS
|
FR |
|
T
|
TIME dotCom Bhd
KLSE:TIMECOM
|
MY |
|
H
|
Hubtown Ltd
NSE:HUBTOWN
|
IN |
|
C
|
Canadian Natural Resources Ltd
SWB:CRC
|
CA |
|
T
|
Tilray Brands Inc
TSX:TLRY
|
US |
|
Moncler SpA
MIL:MONC
|
IT |
|
C
|
CME Group Bhd
KLSE:CME
|
MY |
|
Lasa Supergenerics Ltd
NSE:LASA
|
IN |
Dividends
Dividend Yield
Apex Biotechnology Corp
| Current Yield | |
| Min Yield | |
| Max Yield | |
| Average Yield | |
| Median Yield |
Dividend Per Share
Apex Biotechnology Corp
Apex Biotechnology Corp have
decreased
by 0%.
Payout Ratio
Apex Biotechnology Corp
Peers Comparison
Dividends
Shareholder Yield
Current shareholder yield for Apex Biotechnology Corp is
hidden
.
Shareholder yield represents the total return a company provides to its shareholders, calculated as the sum of dividend yield, buyback yield, and debt paydown yield. What is shareholder yield?
Peers Comparison
Shareholder Yield
Buybacks
Buyback Yield measures how much a company reduces its outstanding shares through repurchases, expressed as a percentage.
This metric directly reflects the company’s efforts to return value to shareholders. By reducing the number of shares, buybacks can increase earnings per share and potentially boost the stock's price.
Peers Comparison
Buybacks
Debt Paydown
Debt Paydown Yield measures the amount of debt a company repays within a specific period, shown as a percentage of its market capitalization.
This metric indicates how the company is using its capital to decrease financial liabilities, which can strengthen its financial health and potentially enhance shareholder value.
Peers Comparison
Debt Paydown
Price Appreciation
Price
Apex Biotechnology Corp
| Average Annual Return | 12.05% |
| Standard Deviation of Annual Returns | 37.01% |
| Max Drawdown | -38% |
| Market Capitalization | 3B TWD |
| Shares Outstanding | 99 950 000 |
| Percentage of Shares Shorted |
N/A
|
Return Decomposition
Main factors of price return
Stock Splits
Apex Biotechnology Corp's latest stock split occurred on Aug 31, 2012
The company executed a 964-for-961 stock split, meaning that for every 961 shares held, investors received 964 new shares.
Before the split, Apex Biotechnology Corp traded at 75.836 per share. Afterward, the share price was about 50.101.
The adjusted shares began trading on Aug 31, 2012. This was Apex Biotechnology Corp's 8th stock split, following the previous one in Jul 1, 2009.
